Page 300 - IJB-10-2
P. 300

International Journal of Bioprinting                              Kidney hydrogel print for renal cancer model




            Funding acquisition: Yibing Wu, Yang Xiang, Peng Wei     doi: 10.1038/s41581-020-00359-2
            Investigation: Miaoben Wu, Hangyu Zhou, Jingying Hu,   9.   Vuong L, Kotecha RR, Voss MH, Hakimi AA. Tumor
               Zonghuan Wang, Yongqi Xu                           microenvironment dynamics in clear-cell renal cell
            Methodology: Jun Yin, Kailei Xu, Tiantian Ren, Yongqi Xu  carcinoma. Cancer Discov. 2019;9(10):1349-1357.
            Writing – original draft: Miaoben Wu                  doi: 10.1158/2159-8290.CD-19-0499
            Writing – review & editing: Jun Yin, Kailei Xu, Tiantian Ren  10.  Meszaros M, Yusenko M, Domonkos L, Peterfi L, Kovacs
                                                                  G, Banyai D. Expression of TXNIP is associated with
            Ethics approval and consent to participate            angiogenesis and postoperative relapse of conventional
            Not applicable.                                       renal cell carcinoma. Sci Rep. 2021;11(1):17200.
                                                                  doi: 10.1038/s41598-021-96220-y
            Consent for publication                            11.  Li S, Huang C, Hu G, et al. Tumor-educated B cells promote
                                                                  renal cancer metastasis via inducing the IL-1β/HIF-2α/
            Not applicable.                                       Notch1 signals. Cell Death Dis. 2020;11(3):163.
                                                                  doi: 10.1038/s41419-020-2355-x
            Availability of data                               12.  Frantz C, Stewart K, Weaver V. The extracellular matrix at a

            The data that support the findings of this study are available   glance. J Cell Sci. 2010;123:4195-4200.
            from the corresponding author upon reasonable request.     doi: 10.1242/jcs.023820
                                                               13.  Majo S, Courtois S, Souleyreau W, Bikfalvi A, Auguste P.
            References                                            Impact of extracellular matrix components to renal cell
                                                                  carcinoma behavior. Front Oncol. 2020;10:625.
            1.   Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal      doi: 10.3389/fonc.2020.00625
               cell carcinoma. Eur Urol. 2019;75(1):74-84.     14.  Afify A, Purnell P, Nguyen L. Role of CD44s and CD44v6 on
               doi: 10.1016/j.eururo.2018.08.036
                                                                  human breast cancer cell adhesion, migration, and invasion.
            2.   Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics,   Exp Mol Pathol. 2009;86(2):95-100.
               2022. CA Cancer J Clin. 2022;72(1):7-33.           doi: 10.1016/j.yexmp.2008.12.003
               doi: 10.3322/caac.21708                         15.  Theocharis A. Versican in health and disease. Connect Tissue
            3.   Safiri S, Kolahi AA, Mansournia MA, et al. The burden of   Res. 2008;49(3):230-234.
               kidney cancer and its attributable risk factors in 195 countries      doi: 10.1080/03008200802147571
               and territories, 1990-2017. Sci Rep. 2020;10(1):13862.  16.  Marinkovich M. Tumour microenvironment: Laminin 332
               doi: 10.1038/s41598-020-70840-2                    in squamous-cell carcinoma.  Nat Rev Cancer. 2007;7(5):
            4.   Makhov P, Joshi S, Ghatalia P, et al. Resistance to systemic   370-380.
               therapies in clear cell renal cell carcinoma: Mechanisms      doi: 10.1038/nrc2089
               and management strategies. Mol Cancer Therap. 2018;17(7):   17.  Astrof S, Hynes R. Fibronectins in vascular morphogenesis.
               1355-1364.                                         Angiogenesis. 2009;12(2):165-175.
               doi: 10.1158/1535-7163.MCT-17-1299                 doi: 10.1007/s10456-009-9136-6
            5.   Nerich V, Hugues M, Paillard MJ, et al. Clinical impact of   18.  Hielscher A, Ellis K, Qiu C, Porterfield J, Gerecht S.
               targeted therapies in patients with metastatic clear-cell renal   Fibronectin deposition participates in extracellular matrix
               cell carcinoma. Onco Targets Ther. 2014;7:365-374.  assembly and vascular morphogenesis. PloS One. 2016;11(1):
               doi: 10.2147/OTT.S56370                            e0147600.
            6.   Goyal  R,  Gersbach  E,  Yang  XJ,  Rohan  SM.  Differential      doi: 10.1371/journal.pone.0147600
               diagnosis  of  renal  tumors  with  clear  cytoplasm:  Clinical   19.  Unal A, West J. Synthetic ECM: Bioactive synthetic
               relevance of renal tumor subclassification in the era of   hydrogels for 3D tissue engineering.  Bioconjug Chem.
               targeted therapies and personalized medicine. Arch Pathol   2020;31(10):2253-2271.
               Lab Med. 2013;137(4):467-480.                      doi: 10.1021/acs.bioconjchem.0c00270
               doi: 10.5858/arpa.2012-0085-RA
                                                               20.  Kabirian F, Mozafari M. Decellularized ECM-derived
            7.   Hui L, Chen Y. Tumor microenvironment: Sanctuary of the   bioinks:  Prospects for  the future.  Methods (San Diego,
               devil. Cancer Lett. 2015;368(1):7-13.              Calif.). 2020;171:108-118.
               doi: 10.1016/j.canlet.2015.07.039                  doi: 10.1016/j.ymeth.2019.04.019
            8.   Jonasch E, Walker CL, Rathmell WK. Clear cell renal cell   21.  Fontana F, Marzagalli M, Sommariva M, Gagliano N,
               carcinoma ontogeny and mechanisms of lethality. Nat Rev   Limonta P. In vitro 3D cultures to model the tumor
               Nephrol. 2021;17(4):245-261.                       microenvironment. Cancers (Basel). 2021;13(12).



            Volume 10 Issue 2 (2024)                       292                                doi: 10.36922/ijb.1413
   295   296   297   298   299   300   301   302   303   304   305